Day: July 22, 2025

MIAMI, FL, July 22, 2025 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that the company will be participating in one-on-one meetings and a fireside chat presentation with investors at the 2025 BTIG Virtual Biotech Conference taking place from July 29-30, 2025. About Veru Inc.Veru is a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases. The Company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin. Enobosarm, a selective androgen receptor modulator (SARM), is being developed as a next generation drug that makes weight...

RESTON, Va., July 22, 2025 (GLOBE NEWSWIRE) — Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating media, today announced that it plans to hold a conference call to discuss its financial results for the second quarter ended June 30, 2025, on Tuesday, August 5thth at 5:00 p.m. ET. Interested parties may access the conference call via live webcast at https://edge.media-server.com/mmc/p/v9nmrwr5 or participate via telephone by registering in advance at https://register-conf.media-server.com/register/BI64af7d0cc9f64239bcba73863c6df19c. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. Following the conference call, a replay will be available via webcast at https://ir.comscore.com/events-presentations. About...

Company Emerges from IPO with $3.5 Million in Cash, Elimination of $5.7 Million in Convertible Debt, and Positions Itself for Scalable Growth into a $6.7 Billion Gen Z Market NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) — Brag House Holdings, Inc. (NASDAQ: TBH) (“Brag House” or the “Company”), the Gen Z engagement platform operating at the intersection of gaming, college sports, and digital media, today announced the filing of its Form 10-Q for the quarter ended March 31, 2025. This is the Company’s first quarterly report since becoming a publicly listed company in March. The filing reflects significant balance sheet improvements following the Company’s initial public offering, as well as strategic positioning ahead of key growth initiatives scheduled for later this year. Key Highlights from the Q1 2025 Filing:Strengthened Capital...

MALVERN, Pa., July 22, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that it plans to release second quarter 2025 financial and operating results prior to market open on Tuesday, August 5, 2025. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day. The conference call will be broadcast live in listen-only mode via webcast at https://edge.media-server.com/mmc/p/d6qidqaw. To listen to the conference call on your telephone, participants may register for the call here. While it is not required, it is recommended you join 10 minutes prior to the event start. About Neuronetics Neuronetics, Inc. believes...

Strategic Partnership with Jiangsu Research Institute of Dalian University of Technology Fuels Entry Into Smart Healthcare Market WUXI, China, July 22, 2025 (GLOBE NEWSWIRE) — LOBO EV Technologies Ltd. (NASDAQ: LOBO) (“LOBO” or the “Company”), a leading manufacturer and innovator in electric mobility and intelligent systems, today announced a strategic partnership with the Jiangsu Research Institute of Dalian University of Technology. This collaboration represents a major advancement in LOBO’s expansion into the smart healthcare sector, as both parties will co-develop and commercialise a next-generation AI-powered senior mobility robot. The robot is expected to launch commercially in October 2025 and is projected to generate approximately USD 3 million in recurring annual revenue. Designed to address the rising global demand for...

Ponto is the world’s first PCIe Gen 5 GPU expansion system purpose-built for commercial datacenters demanding ultra-dense, high-throughput compute performance ESCONDIDO, Calif., July 22, 2025 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS), a leader in PCIe Expansion and rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced the launch of Ponto, the world’s first PCIe Gen 5 expansion platform supporting up to 16 full-size, high-wattage GPUs in a compact 6U rack space. Ponto represents a pivotal advancement in OSS’s commercial strategy as the Company accelerates its focus on high-performance infrastructure solutions for the next generation of datacenter and enterprise AI workloads. “We believe OSS’s new 16-way GPU expansion...

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) — Perella Weinberg Partners (NASDAQ:PWP), a leading global independent advisory firm, today announced that it plans to release its financial results for the second quarter 2025 on Friday, August 1, 2025, before the market opens. Conference Call and Webcast Management will host a conference call and webcast to review Perella Weinberg’s results on the same day at 9:00AM ET. A webcast of the conference call will be available to the public on a listen-only basis and can be accessed through the Investors section of the Company’s website at https://investors.pwpartners.com. The conference call can also be accessed by the following dial-in information:Domestic: (800) 267-6316 International: (203) 518-9783 Conference ID: PWPQ225Replay A replay of the call will also be available two hours after...

DENVER, July 22, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today positive preliminary results from the SAVE Surveillance Registry which is assessing the use of the QUELIMMUNE therapy in the treatment of critically ill pediatric patients with life-threatening Acute Kidney Injury (AKI) and sepsis requiring Renal Replacement Therapy (RRT). Based on the data collected from the first 20 pediatric patients in the SAVE Surveillance Registry, there were no device related safety events with the QUELIMMUNE therapy and 75% of patients have survived through 28 days. These new data are on track to validate or potentially exceed a 50% reduction in loss of life compared to historical data, as reported in Kidney Medicine. SeaStar also reported that additional analyses...

“The Second Team of Naples” is coming off a fifth place finish and Serie A promotion playoffs semifinal appearanceJuve Stabia’s new head coach Ignazio Abate (left) with CEO Filippo Polcino(right)Juve Stabia’s new head coach Ignazio Abate (left) with CEO Filippo Polcino(right)Juve Stabia’s new head coach Ignazio Abate (left) with CEO Filippo Polcino(right) Dublin, Ireland and Naples, Italy, July 22, 2025 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings” or the “Company”) (Nasdaq: BREA), an Ireland-based international holding company focused on expanding its global portfolio of men’s and women’s football clubs through a multi-club ownership (“MCO”) strategy, is pleased to announce that its protfolio club SS Juve Stabia is set to begin the 2025/26 Serie B season with several key signings.  Leading the way is sporting...

MINNEAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the second quarter 2025 on August 12, 2025. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update. To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing 1-800-245-3047 (U.S) or 1-203-518-9765 (international) and using the conference ID: NUWEQ2. An audio archive of the webcast will be available following the call on the Investors page at https://ir.nuwellis.com. About Nuwellis Nuwellis,...